METTL3 and breast cancer: However, METTL3 is an oncogene in most tumors [36–40], although it has both carcinogenic and tumor-suppressing effects in colorectal cancer [41], breast cancer [42], prostate cancer [43], cervical cancer [35], and other cancers.